Fore Pharma’s latest report ‘Global Huntington’s disease Pipeline Capsule – 2013’ provides up-to-date information on key Research and Development (R&D) activities in the global huntington’s disease market. It covers active huntington’s disease pipeline molecules in clinical trials, preclinical research, and drug discovery.
This report helps executives track competitor pipeline molecules. The pipeline data presented in this report can be used for identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.
The scope of the report includes information on huntington’s disease pipeline molecules by clinical trial stages, company, mechanism of action, and country (The US, Germany, France, Italy, Spain, UK, Japan, and Rest of the World). Huntington’s disease pipeline molecules licensing activities are also covered in this report.